RemeGen Co., Ltd. reported earnings results for the half year ended June 30, 2022. For the half year, the company reported sales was CNY 348.78 million compared to CNY 29.19 million a year ago. Net loss was CNY 489.13 million compared to CNY 444.04 million a year ago.

Basic loss per share from continuing operations was CNY 0.96 compared to CNY 0.91 a year ago.